LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Imaging Evaluation of Pulmonary and Non-Ischaemic Cardiovascular Manifestations of COVID-19.

    Cicco, Sebastiano / Vacca, Antonio / Cariddi, Christel / Carella, Rossella / Altamura, Gianluca / Solimando, Antonio Giovanni / Lauletta, Gianfranco / Pappagallo, Fabrizio / Cirulli, Anna / Stragapede, Assunta / Susca, Nicola / Grasso, Salvatore / Ria, Roberto

    Diagnostics (Basel, Switzerland)

    2021  Volume 11, Issue 7

    Abstract: ... ischaemic manifestations of COVID-19, comparing their use in emergency and in intensive care. ... This review deals with different modalities of imaging evaluation in the management of cardiovascular non ... Cardiovascular disease is the most described comorbidity in COVID-19 patients, and it is related to the disease severity ...

    Abstract Coronavirus Disease 2019 (COVID-19) has been a pandemic challenge for the last year. Cardiovascular disease is the most described comorbidity in COVID-19 patients, and it is related to the disease severity and progression. COVID-19 induces direct damage on cardiovascular system, leading to arrhythmias and myocarditis, and indirect damage due to endothelial dysfunction and systemic inflammation with a high inflammatory burden. Indirect damage leads to myocarditis, coagulation abnormalities and venous thromboembolism, Takotsubo cardiomyopathy, Kawasaki-like disease and multisystem inflammatory syndrome in children. Imaging can support the management, assessment and prognostic evaluation of these patients. Ultrasound is the most reliable and easy to use in emergency setting and in the ICU as a first approach. The focused approach is useful in management of these patients due its ability to obtain quick and focused results. This tool is useful to evaluate cardiovascular disease and its interplay with lungs. However, a detailed echocardiography evaluation is necessary in a complete assessment of cardiovascular involvement. Computerized tomography is highly sensitive, but it might not always be available. Cardiovascular magnetic resonance and nuclear imaging may be helpful to evaluate COVID-19-related myocardial injury, but further studies are needed. This review deals with different modalities of imaging evaluation in the management of cardiovascular non-ischaemic manifestations of COVID-19, comparing their use in emergency and in intensive care.
    Language English
    Publishing date 2021-07-15
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662336-5
    ISSN 2075-4418
    ISSN 2075-4418
    DOI 10.3390/diagnostics11071271
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Imaging Evaluation of Pulmonary and Non-Ischaemic Cardiovascular Manifestations of COVID-19

    Sebastiano Cicco / Antonio Vacca / Christel Cariddi / Rossella Carella / Gianluca Altamura / Antonio Giovanni Solimando / Gianfranco Lauletta / Fabrizio Pappagallo / Anna Cirulli / Assunta Stragapede / Nicola Susca / Salvatore Grasso / Roberto Ria

    Diagnostics, Vol 11, Iss 1271, p

    2021  Volume 1271

    Abstract: ... ischaemic manifestations of COVID-19, comparing their use in emergency and in intensive care. ... This review deals with different modalities of imaging evaluation in the management of cardiovascular non ... Cardiovascular disease is the most described comorbidity in COVID-19 patients, and it is related to the disease severity ...

    Abstract Coronavirus Disease 2019 (COVID-19) has been a pandemic challenge for the last year. Cardiovascular disease is the most described comorbidity in COVID-19 patients, and it is related to the disease severity and progression. COVID-19 induces direct damage on cardiovascular system, leading to arrhythmias and myocarditis, and indirect damage due to endothelial dysfunction and systemic inflammation with a high inflammatory burden. Indirect damage leads to myocarditis, coagulation abnormalities and venous thromboembolism, Takotsubo cardiomyopathy, Kawasaki-like disease and multisystem inflammatory syndrome in children. Imaging can support the management, assessment and prognostic evaluation of these patients. Ultrasound is the most reliable and easy to use in emergency setting and in the ICU as a first approach. The focused approach is useful in management of these patients due its ability to obtain quick and focused results. This tool is useful to evaluate cardiovascular disease and its interplay with lungs. However, a detailed echocardiography evaluation is necessary in a complete assessment of cardiovascular involvement. Computerized tomography is highly sensitive, but it might not always be available. Cardiovascular magnetic resonance and nuclear imaging may be helpful to evaluate COVID-19-related myocardial injury, but further studies are needed. This review deals with different modalities of imaging evaluation in the management of cardiovascular non-ischaemic manifestations of COVID-19, comparing their use in emergency and in intensive care.
    Keywords cardiovascular involvement ; cardiovascular magnetic resonance ; coronavirus disease 2019 ; echocardiography ; emergency ; heart computerized tomography ; Medicine (General) ; R5-920
    Subject code 610
    Language English
    Publishing date 2021-07-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top